Clinical Trial Update: Safety and Efficacy of Biphasic Insulin Aspart 50 in Subjects With Type 2 Diabetes [Phase 3]

View source ↗

Summary

A phase 3 clinical trial evaluating the safety and efficacy of Biphasic Insulin Aspart 50 in adults with Type 2 diabetes has completed, with results available f…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Biphasic insulin aspart 50 (insulin aspart, biphasic 50/50)

Snippet

Sponsor: Novo Nordisk A/S | Conditions: Diabetes, Diabetes Mellitus, Type 2 | Phase 3 | Status: COMPLETED